Global Drug Eluting Balloon Market, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 420.0 Million in 2017, and is projected to exhibit a CAGR of 8.1% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
Launch of novel drug eluting balloons by market players to augment the market growth
Key players in the market are focused on launching novel drug eluting balloons in order to treat coronary artery disease and other diseases and address the critical unmet needs of patients. For instance, in October 2014, C.R. Bard’s received U.S. Food and Drug Administration (FDA) approval for Lutonix 035 drug eluting balloon that is used in popliteal arteries in upper legs.
Similarly, in January 2015, Medtronic received clearance from the U.S. FDA for In.Pact Admiral Drug eluting balloon that is used in the superficial femoral and popliteal arteries in upper legs, thereby providing new opportunities for Medtronic and C.R. Bard’s in offering effective treatment options among the fastest growing markets worldwide. In July 2017, Spectranetics Corp. received pre-market approval (PMA) from U.S. FDA for Stellarex drug coated balloon that is used for restoration and maintenance of blood flow to the superficial femoral and popliteal arteries in patients with peripheral arterial disease.
Browse 35 Market Data Tables and 28 Figures spread through 168 Pages and in-depth TOC on ‘Drug Eluting Balloon Market’- Global Forecast to 2026, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) To know the latest trends and insights prevalent in the Drug Eluting Balloon market, click the link below:
Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in November 2014, Medtronic, Inc. acquired Covidien, plc, a company involved in developing and manufacturing a range of medical devices and supplies, including laproscopic surgery, electrosurgery, and vascular therapies. Covidien sells its products in over 150 countries.
Key Takeaways of the Drug Eluting Balloon Market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.